Pfizer announced in a written statement that the third dose of Pfizer-BioNTech vaccine increased the number of antibodies in the body by 3.3 times.
While the coronavirus continues to affect the world, the biggest tool against the virus is the vaccine. The most used vaccine in the world is the USA-based Pfizer and based in Germany BioNTech vaccine developed by companies. This vaccine, which uses the mRNA method, is also actively used in our country.
In the coronavirus vaccination, a new phase has begun to be passed all over the world. In addition to the two-dose coronavirus vaccine, many countries have started to apply the third dose of the vaccine. What kind of protection will the third dose of vaccine provide? The official statement regarding the issue came from Pfizer today. US-based company, third dose of vaccine that you have increased the antibody level 3.3 times announced that it was detected.
Trials were conducted on 306 subjects:
According to a written statement from Pfizer over 306 subjects experiments were made. In the trials, it was found that the third dose of vaccine administered five to eight months after the second dose increased the antibody level by 3.3 times. All details of the research have not yet been published. The side effects of the third dose of vaccine in the subjects participating in the study. no different from the second dose of vaccine was also expressed.
The Pfizer-BioNTech vaccine received full approval last week:
The U.S. Food and Drug Administration approved the Pfizer-BioNTech vaccine for full use last week for those aged 16 and over. The third dose of the vaccine is available only for those 12 years of age and older in the United States. those with immune system disease It has emergency use approval for use.
A World First: USA Grants BioNTech’s Coronavirus Vaccine ‘Full Use Approval’